Back

Randomised placebo controlled trial evaluating the safety and efficacy of intracoronary insulin like growth factor 1 post percutaneous intervention for acute myocardial infarction

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: What's hot in STEMI? Infarction acute phase STEMI ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Eugene Patrick McFadden

Cork University Hospital, Cork (Ireland)

6 More presentations in this session

Presentation thumbnail
The obesity paradox in ST elevation myocardial infarction treated with primary percutaneous coronary intervention: role of infarct size.
Doctor L. Bergamaschi (Bologna, IT)
Abstract Slides
Presentation thumbnail
Complete revascularisation versus stress echocardiography-guided revascularisation in patients with ST-segment elevation myocardial infarction and multivessel disease (CROSS-AMI): a clinical trial.
Doctor R. Calvino Santos (A Coruna, ES)
Abstract Slides
Presentation thumbnail
Prognostic risk stratification in myocardial infarction with non-obstructed coronaries (MINOCA) by conventional risk factors and cardiac magnetic resonance
Doctor A. Ghosh Dastidar (Bristol, GB)
Abstract Slides
Presentation thumbnail
The timing for elective percutaneous coronary intervention and in-hospital outcomes in patients with ST-segment elevation myocardial infarction
Doctor Q. Zhao (Beijing, CN)
Abstract Slides
Presentation thumbnail
High sensitivity troponin T is a stronger predictor than early infarct size determined by CMR for long-term ejection fraction
Doctor M. Mohammad (Lund, SE)
Abstract Slides

Access the full session

Session thumbnail
What's hot in STEMI?

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources